A retrospective analysis of single-port laparoscopy in myoma management

• Published in: Heliyon Vol. 10; no. 15; p. e35821
• Main Authors: Li, Hanqin, You, Wei, Cai, Xiaoji, Jin, Xiaoying, Che, Xuan
• Format: Journal Article
• Language: English
• Published: Elsevier Ltd 15.08.2024; Elsevier
• Subjects: Minimally invasive; Myomectomy; Single-port laparoscopic; Uterine myomas; Single-port laparoscopic; Myomectomy; Uterine myomas; Minimally invasive
• ISSN: 2405-8440; 2405-8440
• DOI: 10.1016/j.heliyon.2024.e35821

This study assesses the effectiveness and safety of single-port laparoscopic myomectomy (SPLM) versus conventional laparoscopic myomectomy (CLM). We conducted a retrospective case-control study at a university tertiary hospital, involving 262 patients treated from July 2020 to December 2022. Participants were divided into two groups: 132 underwent SPLM and 130 underwent CLM. The two groups were comparable in terms of age, body mass index, parity, delivery history, preoperative anemia, number of myomas, and size of the largest myoma. The SPLM group showed a significant reduction in operation time (average 93 min) and estimated blood loss (average 50 ml) compared to the CLM group (average 118.5 min and 100 ml, respectively). Subgroup analysis based on the size, location, and number of myomas further highlighted the advantages of SPLM, particularly for patients with large (diameter ≥8 cm) or multiple myomas (number ≥4). Patient satisfaction was also notably higher in the SPLM group. Single-port laparoscopic myomectomy offers a highly effective, safer, and patient-preferred option for the surgical management of fibroids, especially in cases of large or multiple myomas. These findings suggest that SPLM could become the preferred surgical approach for complex fibroid cases, promising less trauma and quicker recovery for patients.